IDMA PUBLICATIONS

• 
  IDMA Bulletin

  SPECIAL ISSUE ON

  • Address by Dr Viranchi Shah as IDMA's National President at AGM
  • US FDA Registration Requirements - reg.
  • Central Government delegates its powers to the National Financial Reporting Authority - reg
  • Promoting Use of Authentic Copies of the Indian Pharmacopoeia 2018 and its Addenda 2019 & 2021-reg
  • Healthcare, education should be national priority: Tata Sons chairman
  • 43% pharma marketers prefer programmatic messaging platforms in India for improved physician reach: Report
  • Top 5 trends for the pharma industry in 2022
• 
  Indian Drugs
  • Pharmaceutical Chemistry
  • Pharmacognosy
  • Natural Products and Phytochemistry
  • Biotechnology
• 
  57th Annual
  Publication 2019
  • Indian Pharmaceutical Sector: Status Updates.
  • Country-wise Exports of Pharmaceuticals during 2017-2018 and 2018-2019 (April–Aug).
  • New Drugs approved for Marketing by DCG(I) during the period January 1961 to 24th October, 2018.
  • 2018 Generic Drug Access & Savings in USA.
  • Health Statistics of India.

GOVERNMENT NOTIFICATIONS